Blue Cross and Blue Shield of Minnesota policies

Search Blue Cross and Blue Shield of Minnesota's public medical, payment and drug policies by CPT or HCPCS code, keyword or policy number, with links to the payer's own documents. Links open the payer's own document; check its current version before relying on it.

15 policies name 38240, those listing the fewest codes first. A policy that names a code may also list it as excluded.

Blue Cross and Blue Shield of Minnesota policies
PolicyDetailsCodesSource
Hematopoietic Stem Cell Transplantation for Central Nervous System (CNS) Embryonal Tumors and EpendymomaII-130 · Effective Mar 2, 2026 · Commercial, Medicaid17Original policy ↗
Hematopoietic Stem Cell Transplantation for Chronic Myelogenous LeukemiaII-136 · Effective Apr 27, 2026 · Commercial, Medicaid17Original policy ↗
Hematopoietic Stem Cell Transplantation for Hodgkin LymphomaII-135 · Effective Feb 2, 2026 · Commercial, Medicaid17Original policy ↗
Hematopoietic Stem Cell Transplantation for Multiple Myeloma and POEMS SyndromeII-138 · Effective Jan 5, 2026 · Commercial, Medicaid17Original policy ↗
Hematopoietic Stem Cell Transplantation for Myelodysplastic Syndrome and Myeloproliferative NeoplasmsII-133 · Effective Mar 30, 2026 · Commercial, Medicaid17Original policy ↗
Hematopoietic Stem Cell Transplantation for Solid Tumors of ChildhoodII-131 · Effective Aug 31, 2026 · Commercial, Medicaid17Original policy ↗
Hematopoietic Stem Cell Transplantation for Genetic Diseases and Acquired AnemiasII-129 · Effective Feb 2, 2026 · Commercial, Medicaid19Original policy ↗
Hematopoietic Stem Cell Transplantation for Acute Lymphoblastic LeukemiaII-118 · Effective Dec 1, 2025 · Commercial, Medicaid20Original policy ↗
Hematopoietic Stem Cell Transplantation for Acute Myeloid LeukemiaII-115 · Effective Jan 5, 2026 · Commercial, Medicaid20Original policy ↗
Hematopoietic Stem Cell Transplantation for Autoimmune DiseaseII-121 · Effective Dec 1, 2025 · Commercial, Medicaid20Original policy ↗
Hematopoietic Stem Cell Transplantation for Chronic Lymphocytic Leukemia and Small Lymphocytic LymphomaII-122 · Effective Apr 27, 2026 · Commercial, Medicaid20Original policy ↗
Hematopoietic Stem Cell Transplantation for Miscellaneous Solid Tumors in AdultsII-123 · Effective Mar 30, 2026 · Commercial, Medicaid20Original policy ↗
Hematopoietic Stem Cell Transplantation for Non-Hodgkin LymphomaII-117 · Effective Jul 27, 2026 · Commercial, Medicaid20Original policy ↗
Hematopoietic Stem Cell Transplantation for Primary AmyloidosisII-119 · Effective Jun 29, 2026 · Commercial, Medicaid20Original policy ↗
Hematopoietic Stem Cell Transplantation in the Treatment of Germ-Cell TumorsII-114 · Effective Aug 31, 2026 · Commercial, Medicaid20Original policy ↗

Back to Blue Cross and Blue Shield of Minnesota

Disclaimer

The information provided on this page is for general informational purposes only and does not constitute billing, coding, or reimbursement advice. Nothing on this page should be relied upon as a substitute for clinician assessment, professional billing guidance, or as a definitive statement of any payor's billing requirements or policies.

Payor agreements, fee schedules, and billing policies vary and are subject to change. Before submitting any claims related to maternity care services, including claims affected by the 2027 CPT code revisions, please consult the applicable payor agreements, coverage policies, and billing guidelines to confirm current requirements for their specific payor contracts.

Substrate makes no representation or warranty regarding the accuracy, completeness, or timeliness of the payor-specific information presented here. Providers are solely responsible for ensuring that all claims are submitted in accordance with applicable payor requirements, and Substrate assumes no liability for claim denials, underpayments, or other adverse outcomes arising from reliance on this information.